Where and how does the body break down a diabetes drug?

Original Title

In Vitro Metabolic Stability of Exendin-4: Pharmacokinetics and Identification of Cleavage Products

Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms

Summary

This study looks at how fast a medicine called exendin-4 breaks down in parts of a rat’s body, like the liver and kidney.

Sign up to see full results

Get access to research results, context, and detailed analysis.

Surprising Findings

Exendin-4 degrades 13 times faster in kidney tissue than liver tissue in vitro.

Most people assume the liver is the main site of drug breakdown, but here the kidney is far more aggressive—flipping the script on organ roles in metabolism.

Practical Takeaways

Future diabetes drugs could be engineered to resist kidney-specific cleavage, potentially reducing injection frequency.

medium confidence

Unlock Full Study Analysis

Sign up free to access quality scores, evidence strength analysis, and detailed methodology breakdowns.